Singulex

Singulex is a company that is interested in developing solutions that allow people to manage and treat diseases. The company was founded in 2003, in Alameda, California, United States.

Singulex works with life science researchers and clinicians in order to create their molecular detection solutions. Their diagnostic system is capable of detecting and then quantifying protein biomarkers. Singulex has developed their Singulex Clarity system which is an automated platform for in vitro diagnostics. It utilizes Single Molecule Counting to reveal the presence or absence of a disease.

Singulex's platform is capable of detecting infectious and inflammatory diseases, and is being developed to work beyond a point-of-care and to be used outside of a clinical setting. The company is focused in fields of biomarker immunoassay development, high sensitivity immunoassay technologies, and cardiovascular monitoring.

Singulex has collaborated with cardiologists to understand the importance of cardiac troponin levels in blood and how the measurement can be used to determine an individual's risk of having a cardiovascular disease.